Журнал неврологии и нейрохирургических исследований / Journal of Neurology and Neurosurgical Research 3-jild 4-son (2022)
EFFICACY OF NEUROPROTECTIVE DRUGS IN ACUTE REPERFUSION CARDIOEMBOLIC STROKE
Ходжиева Дилбар Таджиевна, Нурова Зарнигор Хикматовна
Annotatsiya
Stroke is the leading cause of disability and the second most common cause of death worldwide. Accurate determination of the mechanism of stroke is crucial, because the most effective care and therapy depend on it. Cardioembolic stroke accounts for 14-30% of all cerebral infarcts. In most cases, recurrence of cardioembolic stroke can be prevented with oral anticoagulants. Therefore, early confirmation of the diagnosis of cardioembolic infarction is extremely important for the patient with cerebral infarction to start anticoagulant therapy for adequate secondary prevention.
острый переод кардиоэмболического инсульта, церебролизин, цитиколин, эдаравон, средняя мозговая артерия, миноциклин, нейропротекторыperiod of cardioembolic stroke, cerebrolysin, citicoline, edaravon, middle cerebral artery, minocycline, neuroprotectorsкардиоэмболик инсултнинг ўткир даври, церебролизин, цитиколин, эдаравон, ўрта мия артерияси, миноциклин, нейропротекторлар
Metadata manbasi: jurnal OAI-PMH arxivi · Sindex toʻliq matnni saqlamaydi, manbaga havola beradi.